# The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

> **NCT05726786** · PHASE3 · RECRUITING · sponsor: **Centre Hospitalier Universitaire Vaudois** · enrollment: 232 (estimated)

## Conditions studied

- Bladder Cancer
- Interstitial Cystitis
- Painful Bladder Syndrome
- Neurogenic Bladder
- Hemorrhagic Cystitis
- Endometriosis
- Bladder Disease

## Interventions

- **DRUG:** Immunonutrition

## Key facts

- **NCT ID:** NCT05726786
- **Lead sponsor:** Centre Hospitalier Universitaire Vaudois
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-10
- **Primary completion:** 2026-08
- **Final completion:** 2026-10
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05726786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05726786, "The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05726786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*